NCT07016958Completed
Carbohydrate Counting Training in Type 2 Diabetes
Effects of Carbohydrate Counting Training Versus Standard Nutritional and Medical Therapy on Glycemic Control and Sarcopenia in Type 2 Diabetes: A Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 12 Jun 2025
Brief summary (registry, in English)
This study aimed to evaluate the efficacy of carbohydrate counting in individuals with type 2 diabetes receiving intensive insulin therapy. In addition, the sarcopenia status in this patient group and the effect of carbohydrate counting on sarcopenia were also evaluated.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 58 (actual)
- First submitted
- 31 May 2025
- Start date
- 1 Aug 2022
- Primary completion date
- 30 Dec 2024
- Lead sponsor
- Medipol University
- Diseases
- Type 2 diabetes
- NCT number
- NCT07016958
What you commit to
- Study type: Interventional
- Participants enrolled: 58
- From 1 Aug 2022 to the primary completion date, 30 Dec 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Receiving glucocorticoid treatment, being fed enterally or parenterally and receiving nutrition treatment due to another/concomitant disease, having end-stage renal or hepatic/ renal disease (other than proteinuria)
Other illness
- Having active proliferative retinopathy, severe nephropathy, severe or newly diagnosed cardiac disease within 6 months or stage III-IV heart failure,
- Having dementia or psychosis and cognitive impairment,
- Having liver disease/microangiopathy diseases
- Having clinical cancer, chronic respiratory disease or amputations,
- Having any disease or condition that would prevent completion of the study.
Other
- Being pregnant or breastfeeding or planning a pregnancy during the study period,
- Discontinuing insulin treatment during the study period
Who the study is looking for
- A history of type 2 diabetes mellitus
- Using insulin for more than one year
- Being over 18 years old
- Receiving basal and bolus insulin treatment
- Not having received carbohydrate counting training before
- Not receiving treatment with sulfanylurea drugs from oral anti-diabetics.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Uskudar Diabetes Polyclinic of the Fatih Sultan Mehmet Training and Research Hospital Coordinator of this site? Confirm its status | Istanbul | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.